Abstract
This chapter discusses the hypoxanthine-guanine phosphoribosyltransferase (HGPRT) deficiency that has two clinical forms: Lesch–Nyhan syndrome (complete HGPRT deficiency) and Kelley–Seegmiller syndrome (partial HGPRT deficiency). Mutations in the X-linked HGPRT gene result in deficiencies of HGPRT enzyme activity, which may cause either a severe form of gout or Lesch–Nyhan syndrome, depending on the residual enzyme activity. Mutations leading to these diseases are heterogenous and include DNA base substitutions and splicing errors. The complete deficiency of HGPRT leads to prominent neurological disturbances in the newborn. Recurrent episodes of coma have been reported. These may be explained by the disruption of the cellular energy metabolism because of purine depletion, consequent to lack of the purine salvage pathway normally provided by the HGPRT.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Metabolic and Degenerative Diseases of the Central Nervous System
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.